Analgesic and disease modifying effects of interferential current in psoriatic arthritis

被引:19
作者
Walker, UA
Uhl, M
Weiner, SM
Warnatz, K
Lange-Nolde, A
Dertinger, H
Peter, HH
Jurenz, SA
机构
[1] Univ Freiburg, Med Klin, Dept Rheumatol & Clin Immunol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Radiol, D-79106 Freiburg, Germany
[3] Ruhr Univ Bochum, Marienhosp Herne, Med Klin 1, D-4630 Bochum, Germany
[4] Univ Freiburg, Dept Nucl Med, D-79106 Freiburg, Germany
[5] Inst Biol Interfaces, Karlsruhe, Germany
关键词
electric stimulation therapy; pain; psoriasis; psoriatic arthritis; therapeutics;
D O I
10.1007/s00296-006-0102-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interferential current (IFC) was suggested to improve the skin manifestations of psoriasis vulgaris, possibly by enhancing the intracellular concentration of cyclic AMP. We assessed the efficacy of IFC on psoriatic arthritis (PsA). Nine consecutive patients were analyzed at baseline and after 16 weeks of IFC therapy. Bipolar IFC was applied twice daily to hands, feet plus all affected joints. IFC improved SF-36 assessed body pain, but not other SF-36 subscales. Morning stiffness, tender joint counts, and physician assessed disease activity improved. In contrast, visual analogue scale assessed pain, CRP and ESR measurements were unchanged. MRI of the most affected hand or foot documented a tendency towards worsened tendinitis, soft tissue swelling, and new joint space narrowing and erosions. Bone scintigraphy showed a trend towards deterioration. New joints became inflamed within treated sites. Thus IFC has analgesic effects in PsA, but does not have a satisfactory disease modifying effect.
引用
收藏
页码:904 / 907
页数:4
相关论文
共 16 条
[1]  
Asadullah Khusru, 2004, Current Drug Targets - Inflammation and Allergy, V3, P185, DOI 10.2174/1568010043343886
[2]   Analgesic effects of transcutaneous electrical nerve stimulation and interferential currents on heat pain in healthy subjects [J].
Cheing, GLY ;
Hui-Chan, CWY .
JOURNAL OF REHABILITATION MEDICINE, 2003, 35 (01) :15-19
[3]   Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study [J].
Clegg, DO ;
Reda, DJ ;
Mejias, E ;
Cannon, GW ;
Weisman, MH ;
Taylor, T ;
BudimanMak, E ;
Blackburn, WD ;
Vasey, FB ;
Mahowald, ML ;
Cush, JJ ;
Schumacher, HR ;
Silverman, SL ;
Alepa, FP ;
Luggen, ME ;
Cohen, MR ;
Makkena, R ;
Haakenson, CM ;
Ward, RH ;
Manaster, BJ ;
Anderson, RJ ;
Ward, JR ;
Henderson, WG .
ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2013-2020
[4]   An investigation into the analgesic effects of different frequencies of the amplitude-modulated wave of interferential current therapy on cold-induced pain in normal subjects [J].
Johnson, MI ;
Tabasam, G .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2003, 84 (09) :1387-1394
[5]   IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis [J].
McInnes, IB ;
Illei, GG ;
Danning, CL ;
Yarboro, CH ;
Crane, M ;
Kuroiwa, T ;
Schlimgen, R ;
Lee, E ;
Foster, B ;
Flemming, D ;
Prussin, C ;
Fleisher, TA ;
Boumpas, DT .
JOURNAL OF IMMUNOLOGY, 2001, 167 (07) :4075-4082
[6]   Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial [J].
Mease, PJ ;
Goffe, BS ;
Metz, J ;
VanderStoep, A ;
Finck, B ;
Burge, DJ .
LANCET, 2000, 356 (9227) :385-390
[7]  
MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8
[8]  
Philipp A, 2000, EUR J DERMATOL, V10, P195
[9]   UP-REGULATION OF MONOCYTIC IL-10 BY TUMOR-NECROSIS-FACTOR-ALPHA AND CAMP ELEVATING DRUGS [J].
PLATZER, C ;
MEISEL, C ;
VOGT, K ;
PLATZER, M ;
VOLK, HD .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (04) :517-523
[10]   CYCLIC-AMP AND CYCLIC-GMP PRODUCTION IN NORMAL AND PSORIATIC EPIDERMIS [J].
ROYER, E ;
CHAINTREUL, J ;
MEYNADIER, J ;
MICHEL, B ;
GUILHOU, JJ ;
DEPAULET, AC .
DERMATOLOGICA, 1982, 165 (06) :533-543